Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists scan brains to uncover the mystery of visual snow

NCT ID NCT06961864

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand what causes Visual Snow Syndrome (VSS), a condition where people see constant flickering dots across their vision. Researchers will use brain scans and visual tests to find which brain pathways are involved. About 100 adults with VSS, migraine, or healthy vision will participate. The goal is to learn more about the condition, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Mar 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for People with Visual Snow Syndrome: * Between the ages of 18 and 60 years old * Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed) * Ability to comply with study instructions * Individuals who have a current diagnosis of VSS from a neuro-ophthalmologist or meet diagnostic criteria of VSS (experience of dynamic dots across the visual field persisting longer than 3 months and at least 2 of the following additional visual symptoms: palinopsia, entoptic phenomena, trails behind moving objects, photophobia, or nyctalopia) * Individuals living in Minnesota within 2 hours of the study site Inclusion Criteria for Non-snow Controls: * Between the ages of 18 and 60 years old * Normal (20/25 or better in each eye) or corrected-to-normal vision (MR-compatible glasses will be provided as needed) * Ability to comply with study instructions * Individuals living in Minnesota within 2 hours of the study site Exclusion Criteria for People with Visual Snow Syndrome: * Not being fluent in English or another language for which interpretation/translation services are available * A diagnosed or self-reported intellectual disability * Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months * Hallucinogenic substance use within the past 12 months or hallucinogenic substance use within 12 months prior to onset of VSS symptoms * Severe central nervous system disease * Head injury with skull fracture or loss of consciousness for more than thirty minutes * Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss) * Age less than 18 years or greater than 60 years * MRI exclusions (for MR visits only): * Metal in the body that cannot be approved by the CMRR safety committee * Pregnancy * Conditions that affect neuro-hemodynamic coupling * Claustrophobia * Inability to lie still for at least an hour * Weight in excess of 440 lbs * CT scan exclusion only: Research-related radiation exposure within the last 12 months * Any vision anomaly aside from VS or refractive error (e.g., strabismus/ crossed eyes, lazy eyes, color blindness) * Current psychotic episode Exclusion Criteria for Non-snow Controls: * Not being fluent in English or another language for which interpretation/translation services are available * A diagnosed or self-reported intellectual disability * Current substance dependence (besides nicotine), or drug dependence with tolerance or withdrawal within past 12 months * Hallucinogenic substance use within the past 12 months * Severe central nervous system disease * Head injury with skull fracture or loss of consciousness for more than thirty minutes * Presence of a physical problem that would render study measures difficult or impossible to administer or interpret (e.g., visual field loss) * Age less than 18 years or greater than 60 years * MRI exclusions (for MR visits only): * Metal in the body that cannot be approved by the CMRR safety committee * Pregnancy * Conditions that affect neuro-hemodynamic coupling * Claustrophobia * Inability to lie still for at least an hour * Weight in excess of 440 lbs * CT scan exclusion only: Research-related radiation exposure within the last 12 months * Any vision anomaly or refractive error (e.g. strabismus/ crossed eyes, lazy eyes, color blind) * A personal history of VSS symptoms or a diagnosis with VSS * Current psychotic episode

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.